GlassScriptPhysician profile
Celeste M Miller
NPI 1477870020
$2,336.47
in general payments reported to CMS, 2019-2025
33 companies · $600 in 2025
The $600 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $63.92 · 2021: $86.99 · 2022: $245 · 2023: $353 · 2024: $666 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,618.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $306.97 | 2022-2025 | |
| Astellas Pharma US INC | $241.23 | 2019 | |
| Amgen INC. | $202.98 | 2019-2025 | Repatha, Repatha, Otezla |
| Esperion Therapeutics, INC. | $190.22 | 2024-2025 | Nexletol |
| Novo Nordisk INC | $146.83 | 2019-2025 | Ozempic, Wegovy |
| Abbott Laboratories | $134.32 | 2019-2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $123.21 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Currax Pharmaceuticals LLC | $105.10 | 2022-2023 | Contrave |
| Abbvie INC. | $95.69 | 2021-2025 | |
| Phathom Pharmaceuticals, INC. | $88.39 | 2024-2025 | Voquezna |
| Azurity Pharmaceuticals, INC. | $80.10 | 2024-2025 | Edarbyclor, Edarbi |
| Pfizer INC. | $62.40 | 2022-2024 | |
| Exact Sciences Corporation | $55.33 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $48.44 | 2022-2025 | Shingrix, Arexvy |
| Boston Scientific Corporation | $41.97 | 2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $36.90 | 2024-2025 | Farxiga |
| Philips North America LLC | $34.50 | 2025 | Ecc Solutions |
| Bayer Healthcare Pharmaceuticals INC. | $31.83 | 2025 | |
| Allergan, INC. | $29.58 | 2019-2020 | |
| Vital Connect, INC | $29.36 | 2024 | Vitalpatch Rtm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.23 | 2024 | Lifevest |
| Medtronic, INC. | $26.45 | 2025 | Venaseal |
| Inspire Medical Systems, INC. | $24.06 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $23.15 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $21.85 | 2023 | Arcalyst |
| Ionis Pharmaceuticals, INC. | $21.68 | 2025 | Tryngolza |
| Lantheus Medical Imaging, INC. | $18.01 | 2023 | Definity |
| Heartflow, INC. | $16.43 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $15.91 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $15.69 | 2024 | Arcalyst |
| Vivaquant INC, Dba Rhythm Express | $14.48 | 2025 | Rhythm Express |
| Linus Health, INC. | $12.90 | 2024 | Core Cognitive Evaluation |
| Merck Sharp & Dohme LLC | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celeste Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.